Skip to main content

Table 2 Relationship between selected clinical and laboratory parameters and BMI SDS, total weight loss and rate of weight loss at assessment of 268 postmenarcheal adolescent girls presenting with an eating disorder

From: Influence of premorbid BMI on clinical characteristics at presentation of adolescent girls with eating disorders

Dependent variable

Independent variables

Beta

R2

p

Pulse frequency

BMI SDS

0,326

0,188

<0,001

Weight loss

−0,199

0,070

<0,001

Final rate of weight loss

−0,189

0,027

p = 0,003

Systolic blood pressure

BMI SDS

0,311

0,152

<0,001

Weight loss

-

-

-

Final rate of weight loss

−0,249

0,056

<0,001

Plasma potassium

BMI SDS

-

-

-

Weight loss

-

-

-

Final rate of weight loss

-

-

-

Plasma phosphate

BMI SDS

-

-

-

Weight loss

−0,141

0,020

p = 0,030

Final rate of weight loss

-

-

-

Serum free triodothyronine

BMI SDS

0,191

0,033

<0,001

Weight loss

−0,347

0,267

<0,001

Final rate of weight loss

−0,315

0,107

<0,001

Serum insulin-like growth factor 1

BMI SDS

0,260

0,073

<0,001

Weight loss

−0,245

0,048

<0,001

Final rate of weight loss

−0,333

0,275

<0,001

Serum luteinizing hormone

BMI SDS

0,210

0,086

p = 0,003

Weight loss

-

-

-

Final rate of weight loss

−0,227

0,040

p = 0,001

  1. The dependent variables were entered against BMI SDS, weight loss and the rate of weight loss immediately preceding assessment in a linear stepwise regression analysis
  2. BMI SDS BMI standard deviation score